Skip to main navigation
AASLD Family of Websites: The Liver Meeting
AASLD.org AASLD Foundation LiverLearning Careers Journals Liver Fellow Network HCV Guidelines
Home

TLM Main Navigation

  • Claim CE Credits
  • For Industry
    Why Exhibit Reserve a Booth Exhibitor Resources
  • Attend
    Housing Venue Visa Letter
  • Program
    Call for Abstracts Open On-Site Guides
  • Submit an Abstract

Novel Therapeutic Approaches for MASH

Nov 13 2023
Ballroom BC - Hynes Convention Center
8:30 - 10:00 AM EST

Speakers

Rohit Loomba

University of California, San Diego

Arun J. Sanyal

Virginia Commonwealth University

Torsten Wuestefeld

Nanyang Technological University

Tarana Gupta

Pandit Bhagwat Dayal Sharma Institute of Medical Sciences, Rohtak

Siham Abdelgani

Uth San Antonio

Helen Huang

Perelman School of Medicine, University of Pennsylvania

Description

Abstracts

  • Itfg1: A PROMISING TARGET FOR ENHANCED LIVER REGENERATION AND CHRONIC LIVER DISEASE TREATMENT
  • TRIPLE HORMONE RECEPTOR AGONIST RETATRUTIDE RESOLVES STEATOSIS IN >85 % OF SUBJECTS WITH MASLD AND OBESITY IN ASSOCIATION WITH IMPROVED METABOLIC HEALTH
  • RELATIONSHIP OF NON-INVASIVE MEASURES WITH HISTOLOGICAL RESPONSE IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND FIBROSIS: 52-WEEK DATA FROM THE PHASE 3 MAESTRO-NASH TRIAL
  • SAROGLITAZAAR IS EFFECTIVE IN IMPROVING LIVER STIFFNESS MEASUREMENT AND LIVER ENZYMES IN NONALCOHOLIC STEATOHEPATITIS
  • EMPAGLIFLOZIN IS EQUALLY EFFECTIVE IN REDUCING LIVER FAT CONTENT IN T2DM PATIENTS AND IN NON-DIABETIC INDIVIDUALS, A RANDOMIZED TRIAL
  • DEEP PHENOTYPING OF TM6SF2 TO CHARACTERIZE HEPATIC STEATOSIS, PLASMA LIPID TRAITS, AND METABOLIC RISK FACTORS USING A GENOME-FIRST APPROACH
About Us
  • AASLD Foundation
  • About AASLD
Legal
  • Abstract Policies
  • Accreditation and Designation Statements
  • Disclosure Policy
  • Embargo Policy
  • Ethics Policy
  • Event Registration Policies
  • Limited License for Use
Get In Touch
  • Contact
Follow Us
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
Copyright © 2025 American Association for the Study of Liver Diseases
AASLD: The Liver Meetings - Nov. 15-19, 2024